Home › Core › ISCC-IDs › 28CrZZjji9oFS

View ISCC-ID

Core Data

28CrZZjji9oFS
ISCC-ID - digital asset identifier
CCLarNa742eTm-CTb4iriSynrvN-CD9D9aegLp6y4-CRh7DGPToq2Qx
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

efficacy and safety of docetaxel plus oxaliplatin and capecitabine in the first line treatment of advanced gastric adenocarcinom

Ledger Reference

coblo
Source Ledger/Blockchain
35410
N-th ISCC Decleration on source ledger
73236075387835faa6f0e8ca54e1bfc6598b5bea5d8a222763bbf8e4da15f159
Hash of block that includes the ISCC-DECLARATION
12c1294e4a3c6397c85230a502998b714e7b1ec4ee39588f2c6e2d50e2d85637
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Ying Liu", "@type": "Person"}, {"name": "Zhengbao Ye", "@type": "Person"}, {"name": "Wenqi Xi", "@type": "Person"}, {"name": "Tao Ma", "@type": "Person"}, {"name": "Min Shi", "@type": "Person"}, {"name": "Liu Yang", "@type": "Person"}, {"name": "Zhenggang Zhu", "@type": "Person"}, {"name": "Jun Zhang", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc3787590?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Hindawi Limited", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1155/2013/971096", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCLarNa742eTm-CTb4iriSynrvN-CD9D9aegLp6y4-CRh7DGPToq2Qx", "propertyID": "ISCC"}], "datePublished": "2013-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close